However, measurable immune responses and control of tumor growth were achieved only by adopting complex protocols involving adoptive transfer of antigen-specific transgenic T cells and co-administration of anti-CD40, Flt3, GMCSF and/or CpG. The gene discussed is CD40; the disease is neoplasm.